Similar articles

• Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

  Francis GJ, Martinez JA, Liu WQ, Xu K, Ayer A, Fine J, Tuor UI, Glazner G, Hanson LR, Frey WH 2nd, Toth C. Francis GJ, et al. Brain. 2008 Dec;131(Pt 12):3311-34. doi: 10.1093/brain/awn288. Epub 2008 Nov 16. Brain. 2008. Retraction in: Brain. 2014 Jun;137(Pt 6):e283. doi: 10.1093/brain/awu127. PMID: 19015157 Retracted.
• Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).

  Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H. Akisaki T, et al. Diabetes Metab Res Rev. 2006 Sep-Oct;22(5):376-84. doi: 10.1002/dmrr.632. Diabetes Metab Res Rev. 2006. PMID: 16506272
• Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

  Brands AM, Kessels RP, de Haan EH, Kappelle LJ, Biessels GJ. Brands AM, et al. Eur J Pharmacol. 2004 Apr 19;490(1-3):159-68. doi: 10.1016/j.ejphar.2004.02.053. Eur J Pharmacol. 2004. PMID: 15094082 Review.
• Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.

  van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J. van Elderen SG, et al. Neurology. 2010 Sep 14;75(11):997-1002. doi: 10.1212/WNL.0b013e3181f25f06. Neurology. 2010. PMID: 20837967 Clinical Trial.
• [Diabetes mellitus and cognition: is there a link?].

  Barrou Z, Lemaire A, Boddaert J, Verny M. Barrou Z, et al. Psychol Neuropsychiatr Vieil. 2008 Sep;6(3):189-98. doi: 10.1684/pnv.2008.0136. Psychol Neuropsychiatr Vieil. 2008. PMID: 18786878 Review. French.